SG Americas Securities LLC acquired a new stake in shares of AMN Healthcare Services Inc (NYSE: AMN) in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 50,561 shares of the company's stock, valued at approximately $979,000. SG Americas Securities LLC owned about

AMN Healthcare (AMN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Shares of AMN Healthcare Services Inc (NYSE: AMN - Get Free Report) have been given an average rating of "Hold" by the nine research firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have assigned a

AMN Healthcare Services Inc (NYSE: AMN - Get Free Report) has been given a consensus rating of "Hold" by the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and five have issued a buy

Federated Hermes Inc. grew its stake in shares of AMN Healthcare Services Inc (NYSE: AMN) by 307.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 651,409 shares of the company's stock after acquiring an additional 491,454 shares during the period.

AMN Healthcare Services (NYSE: AMN - Get Free Report) and Getinge (OTCMKTS:GNGBY - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation. Risk and Volatility AMN Healthcare Services has a

AMN Healthcare Services Inc (NYSE: AMN - Get Free Report) has received a consensus recommendation of "Hold" from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating on the company.

AMN Healthcare beats third-quarter 2025 earnings and revenue estimates despite lower margins and year-over-year declines across key segments.

AMN Healthcare Services, Inc. ( AMN ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Randle Reece - Senior Director of Investor Relations & Strategy Caroline Grace - President, CEO & Director Brian Scott - CFO & COO Conference Call Participants Trevor Romeo - William Blair & Company L.L.C., Research Division Kevin Fischbeck - BofA Securities, Research Division Tobey Sommer - Truist Securities, Inc., Research Division Albert Rice - UBS Investment Bank, Research Division Mark Marcon - Robert W.

The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.